Skip to content
← Full study record

NCT01096368 · OUTCOME

OS in Children With Incomplete Resection After Initial Surgery Who Then Achieved CR After Induction Chemotherapy or GTR/NTR After Second Surgery and Are Treated With Post-radiation Maintenance Chemotherapy or Post-radiation Observation Only

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma · Source last updated 2026-04-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
Up to 10 years after enrollment. 5-year estimates of OS are presented.

What was measured

Kaplan-Meier estimates of OS are calculated from randomization date to death from any cause. The comparison between randomized arms (post-radiation maintenance chemotherapy versus post-radiation observation only) for this stratum is conveyed by the hazard ratio and 95% Wald confidence interval.

Analysis population: Eligible, randomized participants (intent-to-treat) in stratum 2 (induction chemotherapy or second surgery required)

Groups in this outcome

Arm II: Randomized to Radiation With Maintenance Chemotherapy in Stratum 2

Patients with supratentorial ependymoma (Grade II without GTR1 or Grade III) or any infratentorial ependymoma with incomplete resection after initial surgery and then CR after induction chemotherapy, or patients with GTR/NTR after second surgery (stratum 2) are randomized to undergo conformal radiotherapy over 6-7 weeks followed by maintenance chemotherapy.

Arm III: Randomized to Radiation Only in Stratum 2

Patients with supratentorial ependymoma (Grade II without GTR1 or ST Grade III) or any infratentorial ependymoma (Grade II or III) with incomplete resection after initial surgery and then CR after induction chemotherapy, or patients with GTR/NTR after second surgery (stratum 2) are randomized to undergo conformal radiotherapy over 6-7 weeks and then undergo observation.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm II: Randomized to Radiation With Maintenance Chemotherapy in Stratum 220
Arm III: Randomized to Radiation Only in Stratum 219

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Arm II: Randomized to Radiation With Maintenance Chemotherapy in Stratum 269.2Not reported40.286.2Not reported
Arm III: Randomized to Radiation Only in Stratum 289.5Not reported64.197.3Not reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. ci Lower Limit
    0.724
    ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    ci Upper Limit
    17.902
    estimate Comment
    Hazard ratio is based on hazard of death for Arm II over hazard of death for Arm III.
    group Description
    In stratum 2, it was also planned to test the superiority of RT+maintenance vs. RT alone as measured by OS using the hazard ratio via a 2-sided log-rank test. A two-sided significance threshold of 5% was planned for this comparison.
    group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    0.094
    p Value Comment
    P-value is two-sided and not adjusted for multiple comparisons for this exploratory subgroup comparison.
    param Type
    Hazard Ratio (HR)
    param Value
    3.601
    statistical Method
    Log Rank
Complete source fields
analyses
  1. ci Lower Limit
    0.724
    ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    ci Upper Limit
    17.902
    estimate Comment
    Hazard ratio is based on hazard of death for Arm II over hazard of death for Arm III.
    group Description
    In stratum 2, it was also planned to test the superiority of RT+maintenance vs. RT alone as measured by OS using the hazard ratio via a 2-sided log-rank test. A two-sided significance threshold of 5% was planned for this comparison.
    group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    0.094
    p Value Comment
    P-value is two-sided and not adjusted for multiple comparisons for this exploratory subgroup comparison.
    param Type
    Hazard Ratio (HR)
    param Value
    3.601
    statistical Method
    Log Rank
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        40.2
        upper Limit
        86.2
        value
        69.2
      2. group Id
        OG001
        lower Limit
        64.1
        upper Limit
        97.3
        value
        89.5
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    2. group Id
      OG001
      value
      19
    units
    Participants
description
Kaplan-Meier estimates of OS are calculated from randomization date to death from any cause. The comparison between randomized arms (post-radiation maintenance chemotherapy versus post-radiation observation only) for this stratum is conveyed by the hazard ratio and 95% Wald confidence interval.
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients with supratentorial ependymoma (Grade II without GTR1 or Grade III) or any infratentorial ependymoma with incomplete resection after initial surgery and then CR after induction chemotherapy, or patients with GTR/NTR after second surgery (stratum 2) are randomized to undergo conformal radiotherapy over 6-7 weeks followed by maintenance chemotherapy.
    id
    OG000
    title
    Arm II: Randomized to Radiation With Maintenance Chemotherapy in Stratum 2
  2. description
    Patients with supratentorial ependymoma (Grade II without GTR1 or ST Grade III) or any infratentorial ependymoma (Grade II or III) with incomplete resection after initial surgery and then CR after induction chemotherapy, or patients with GTR/NTR after second surgery (stratum 2) are randomized to undergo conformal radiotherapy over 6-7 weeks and then undergo observation.
    id
    OG001
    title
    Arm III: Randomized to Radiation Only in Stratum 2
param Type
NUMBER
population Description
Eligible, randomized participants (intent-to-treat) in stratum 2 (induction chemotherapy or second surgery required)
reporting Status
POSTED
time Frame
Up to 10 years after enrollment. 5-year estimates of OS are presented.
title
OS in Children With Incomplete Resection After Initial Surgery Who Then Achieved CR After Induction Chemotherapy or GTR/NTR After Second Surgery and Are Treated With Post-radiation Maintenance Chemotherapy or Post-radiation Observation Only
type
OTHER_PRE_SPECIFIED
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice